North America Facial Injectables Market: Snapshot

Owing to the rising disposable incomes and changing lifestyles, there has been a continued rise of facial injectables demand across North America. The market for facial injectables is estimated to be growing a faster pace due to emerging physical appearance obsession globally. The focus on aesthetics and the desire to become young is also anticipated to increase the demand for facial surgeries in the years to come. Not only that, the rise in longevity of these injectables effects has also gained momentum in North America market.

north america facial injectables market The North America market for injectables is anticipated to rise to US$5.8 bn by 2024 from that of US$2.1 bn of 2015. The market is expected to rise at a promising 12.0% CAGR during the forecast years of 2016 and 2024.

Botox Making Extensive Demand in Market for Skin Rejuvenation

Based on product segmentation of facial injectables in the market it can be categorized into Collagen, botulinum toxin, particle and polymer fillers, and hyaluronic acid. With a major share accounting in the market as per 2015, botulinum toxin has been leading. The sub segments of collagen being human based and porcine or bovine-based and the sub segments of particle and polymer fillers being calcium hydroxyapatite, Poly-L-Lactic acid and Polymethylmethacrylate Beads or PMMA microspheres). However, botox has been attributing to effectiveness mainly in reducing wrinkles and face lines and skin rejuvenation, making an extensive demand in the market. The segment is estimated to rise with a CAGR of 12.7% within the forecast period of 2016 to 2024.

Treatment wise, the regional market for facial injectables is segmented into lip augmentation, facial pain, and wrinkle treatment. Owing to these less recovery time and minimally invasive strategies, the facial injectables are being widely used in the cosmetics industry.

Based on end user segmentation, the North America market for facial injectables market is segmented into physician clinics, dermatology clinics, cosmetic centers, hospitals and ambulatory surgical centers. The expanding awareness of beauty and aesthetics in skin rejuvenation is anticipated to fuel the injectable filler demand in the market.

U.S. Growing at Rapid Pace due to Rising Demand for Anti-aging Treatment

The market for facial injectables in North America is segmented into Canada, and U.S. in terms of geography. A large portion of the share of facial injectables in North America came from the U.S. according to the 2015 reports. Owing to the rise in demand for dermal fillers in anti-aging treatment, the market for facial injectables in North America is experiencing a rapid growth.

According to The American Society for Aesthetic Plastic Surgery prediction, the popularity of people with skin problems will continue to rise and treatment for which will encourage the uptake of both surgical and non- surgical aesthetic procedures across the region followed by Canada and the Rest of North America.

The key players in the market for facial injectables in North America are Bloomage BioTechnology Corporation Limited, Ipsen Group, Allergan Plc, Prollenium Medical Technologies Inc., Galderma S.A. (Nestle), and Merz Pharma & Co. KGaA. Among these, Allergan Plc holds a dominant share in the market making the market fairly monopolistic in nature.

North America Facial Injectables Market: Overview

This report on the North America facial injectables market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments. A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the North America facial injectables market.

North America Facial Injectables Market: Research Methodology

The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2014 to 2024, considering the macro and micro environmental factors. Growth rates for each segment within the North America facial injectables market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.

Market revenue in terms of US$ Mn for the period between 2014 and 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all the segments, considering 2015 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as growing global obsession with physical appearance and the desire to look young and rising inclination toward minimally invasive surgeries, in historical year-on-year growth have been taken into consideration while estimating the market size.

North America Facial Injectables Market: Segmentation

Based on product type, the North America facial injectables market has been segmented into Product Type – Botulinum Toxin; Hyaluronic Acid; Collagen: Porcine/ Bovine based & Human based; Particle & Polymer Fillers (PPF): Polymethylmethacrylate Beads (PMMA microspheres), Poly-L-Lactic Acid & Calcium Hydroxyapatite). The market has been further studied from the point of view of major treatment types. Based on treatment type, the market has been categorized into facial pain, wrinkle treatment, lip augmentation and others. Based on end users, the market has been segmented into hospitals, ambulatory surgical centers, cosmetic centers, dermatology clinics and physician clinics.

North America Facial Injectables Market: Regional Outlook

Geographically, the North America facial injectables market has been segmented into: the U.S. & Canada. The report also profiles major players in the facial injectables market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments.

Key Players Mentioned in this Report are:

Key companies profiled in the report Allergan Plc., Galderma S.A. (Nestle), Merz Pharma & Co. KGaA, Prollenium Medical Technologies Inc., Ipsen Group and Bloomage BioTechnology Corporation Limited.

The North America facial injectables market has been segmented as follows:

North America Facial Injectables Market, by Product Type

  • Botulinum Toxin
  • Hyaluronic Acid
  • Collagen
    • Porcine/ Bovine-Based
    • Human Based
  • Particle & Polymer Fillers (PPF)
    • Polymethylmethacrylate Beads (PMMA microspheres)
    • Poly-L-Lactic Acid
    • Calcium Hydroxyapatite

North America Facial Injectables Market, by Treatment

  • Facial Pain
  • Wrinkle Treatment
  • Lip Augmentation
  • Others

North America Facial Injectables Market, by End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Cosmetic Centers
  • Dermatology Clinics
  • Physician Clinics

North America Facial Injectables Market, by Country

  • North America
    • U.S.
    • Canada
.